TrialScope Launches Trial Results Summaries Portal

TrialScope, a provider of clinical trial transparency and compliance solutions, has launched the Trial Results Summaries Portal, a publicly accessible website where clinical trial sponsors can inform and educate trial participants and the general public about trial results through a non-promotional and unbiased venue.

The Trial Results Summaries Portal, developed in partnership with AstraZeneca, provides a centrallocation for sponsors to communicate Trial Result Summaries in multiple languages to trial participants. A Trial Result Summary includes information about the purpose, the results, and other facts about the study, but importantly maintains patient confidentiality protecting all personal data. Content of the Trial Results Summary is guided by Regulatory policy and recommendations, which includes increased and consistent communications with trial participants, supporting health literacy efforts, and improved patient engagement by helping patients understand how their participation is supporting clinical research. It also enables sponsors to meet their ethical, corporate and legal reporting obligations. 

Julie Holtzople, Clinical Trial Transparency Operations Director for Astra Zeneca, championed the project as a win-win scenario for clinical trial sponsors, the public and trial participants. "Through our experience, we know that trial participants want the ability to easily find information about their study. This is why we have invested in this important tool, which we hope will become a central location for studies from many sponsors. Ideally, it is best for patients and the public if they can find trial summary results from across the globe in one central place."  

Mark Heinold, TrialScope chief executive officer, noted, "Our collaboration with the AstraZeneca team was an exceptional experience. We all had the same goal of improving transparency in mind as we developed the concept and validated its effectiveness with external patient groups. The portal represents a significant process upgrade for any clinical trial sponsors who are still distributing trial results through inefficient and inconsistent paper-based processes. Our subscription service for trial participants closes the loop on patient communications and creates a new standard of practice for patient interactions."